A carregar...

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

BACKGROUND: This study aims to compare the efficacy and safety between zoledronic acid combined with calcium and calcium alone to prevent aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole. METHODS: One hundred twenty patients were randoml...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Sun, Shengliang, Wang, Fuchao, Dou, Honglei, Zhang, Longqiang, Li, Jiwen
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063560/
https://ncbi.nlm.nih.gov/pubmed/27785049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S115058
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!